Endocrinology
From the Journals
Levothyroxine overprescribing common, consistent over time
A study detailing the consistent overuse of the thyroid replacement drug over a decade should be a “call to action” for doctors to stop treating...
Conference Coverage
ADA/EASD draft guidance aims to bring adults with type 1 diabetes out of shadows
The new draft ADA/EASD consensus report offers an algorithm for diagnosing type 1 diabetes, a clear call for state-of-the-art technology, and an...
Conference Coverage
Testosterone replacement shows CV benefit in hypogonadal men
Among men with hypogonadism who received testosterone replacement every 3 months, cardiovascular parameters were better and there were fewer...
Conference Coverage
Not so crazy: Pancreas transplants in type 2 diabetes rising
Simultaneous pancreas-kidney transplants are increasingly performed in patients with type 2 diabetes and chronic kidney disease.
From the Journals
Meta-analysis supports cardiovascular benefits of EPA
Omega-3 fatty acids improved cardiovascular outcomes, with a greater risk reduction in studies of eicosapentaenoic acid alone rather than combined...
News
New drug, finerenone, approved for slowing kidney disease in diabetes
Finerenone (Kerendia) is the first agent approved from a novel class, the nonsteroidal mineralocorticoid receptor antagonists. But its role in...
Feature
‘Treat youth with gender dysphoria as individuals’
Keira Bell regrets her decision to transition at age 16, saying she only received three counseling sessions prior to endocrinology referral.
Conference Coverage
Nocturnal hypoglycemia halved with insulin degludec vs. glargine
Researchers pitted degludec against glargine U100 in the toughest patients with type 1 diabetes, those who had severe nocturnal hypoglycemia.
Conference Coverage
SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight loss
For patients with type 2 diabetes, doubling the weekly semaglutide dose modestly improved glycemic control and weight loss while maintaining...
Conference Coverage
Unmanaged diabetes, high blood glucose tied to COVID-19 severity
Findings suggest in part that hospitalized COVID-19 patients need aggressive treatment of hyperglycemia, regardless of the diagnosis of diabetes...
From the Journals
Sotagliflozin use in T2D patients linked with posthospitalization benefits in analysis
The paper’s outcome measure may be a meaningful, patient-centered way of capturing disease burden, according to the authors.